期刊文献+

神经肽Y和5-羟色胺在腹泻型肠易激综合征模型大鼠中表达的研究 被引量:40

Expression of NPY and 5-HT in rat model of diarrhea-predominant irritable bowel syndrome
暂未订购
导出
摘要 目的探讨神经肽Y(NPY)和5-羟色胺(5-HT)对腹泻型肠易激综合征(D-IBS)发病机制的影响,为从脑肠轴方面分析研究D-IBS的发生机制提供理论依据。方法采用母乳分离+醋酸刺激+四肢束缚制作D-IBS大鼠模型,通过免疫组化法检测大鼠结肠组织中5-HT的蛋白表达水平,采用实时荧光定量RT-PCR检测大鼠下丘脑和结肠组织中NPY mRNA的表达。结果与正常组相比,NPY mRNA表达在肠易激综合征模型大鼠结肠和下丘脑组织均降低(P<0.05)。5-HT蛋白表达在模型大鼠结肠中升高(P<0.05)。结论脑肠肽NPY和5-HT可能参与D-IBS脑肠轴异常机制的调节。 Aim To investigate expression of neu-ropeptide Y(NPY) and 5-hydroxy tryptamine (5-HT) in diarrhea-predominant irritable bowel syndrome (D- IBS) and provide theoretical basis for mechanism of D- IBS from the aspect of brain-gut axis. Method A rat model of D-IBS was established with the use of separation of breast milk + stimulation of acetic acid + con- straint of the four limbs. Expression of 5-HT protein was detected in colon of rat with immunohistochemistry and expression of NPY mRNA was detected in colon and hypothalamus of rat with real-time fluorescence quantitative reverse transcription polymerase chain reaction ( RT-PCR ). Result Compared with normal group, expression of NPY mRNA were significantly de- creased in colon and hypothalamus of D-IBS model group (P 〈 0.05). In addition, 5-HT protein expression was markedly increased in colon of D-IBS model group (P 〈 0. 05 ). Conclusion NPY and 5-HT may be involved in regulatory mechanism of D-IBS.
出处 《中国药理学通报》 CAS CSCD 北大核心 2012年第7期916-920,共5页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 81073160) 广东省自然科学基金资助项目(No 10151040701000041) 广州市科技局重大科技生物专项资助项目(No 2008AJ-E4101-6) 广东省科技厅科技资助项目(No 2010B030700065)
关键词 神经肽Y 5-羟色胺 腹泻型肠易激综合征 脑肠轴 实时荧光定量PCR 下丘脑 结肠 neuropeptider Y 5-hydroxy tryptamine diarrhea-predominant irritable bowed syndrome braingut axis reverse transcription polymerase chain reaction hypothalamus colon
  • 相关文献

参考文献4

二级参考文献62

  • 1刘红娟,王文宇,孙宏晨.鼠原发性三叉神经痛下丘脑β内啡肽含量测定[J].中华口腔医学杂志,2005,40(2):154-155. 被引量:5
  • 2高云,梁尚栋,邵立健,穆松牛,徐昌水,张春平.川芎嗪对P2X_3受体介导的神经病理痛的作用研究[J].中国药理学通报,2007,23(4):458-462. 被引量:9
  • 3夏德雨,王景杰,颜云龙,王伟,黄裕新.直肠扩张刺激引起IBS大鼠痛行为学以及腹肌电活动的变化[J].胃肠病学和肝病学杂志,2007,16(3):260-263. 被引量:8
  • 4Small P K,Loudon M A,Han C M,et al.Large scale ambulatory study of post prandial jejunal motility in irritable bowel syndrome[J].Scand J Gastroemerol,1997,32:39.
  • 5Whitehead W E,Holtkotter B,Enck P,et al.Tolerance for rectosigmoid distension in irritable bowel syndrome[J].Gastroenterology,1990,98:1187.
  • 6Talley N,Spiler R C.Irritable bowel syndrome:a little understood organic bowel disease?[J].Lancet,2002,360:555-64.
  • 7Boyce P M,Talley N J,Burke C,et al.Epidemiology of the functional gastrointestinal disorders diagnosed according to RomeⅡcriteria:an Australian population based study[J].Intern Med J,2006,36:28-36.
  • 8[1]Bensoussan A,Talley NJ,Hing M,et al.Chinese herbal medicine for irritabe bowel syndrome[J].JAMA,1998,280(18):1585.
  • 9[6]Pang X,Boucher W,Triadafilopoulos G,et al.Mast cell and substanceP-positive nerve involvement in apatient with both irritable syndrome and interstitial cystitis[J].Urology,1996,47(3):436-438.
  • 10[7]Morise K,Furusawa A,Yamamoto H,et al.Role of gut hormones in irritable bowel syndrome[J].NipponRinshon,1992,50(11):2697-2702.

共引文献82

同被引文献521

引证文献40

二级引证文献496

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部